海洋バイオテクノロジー市場 - 世界の産業規模、シェア、動向、機会、予測：種類別、技術別、用途別、エンドユーザー業界別、地域別、競合別、2020年～2030年

海洋バイオテクノロジーの世界市場規模は2024年に63億5,000万米ドルとなり、予測期間中のCAGRは7.08%で2030年には95億7,000万米ドルに達すると予測されています。

海洋バイオテクノロジーの世界市場は、海藻関連製品のような海洋由来の天然製品に対する需要の高まりや、持続可能な天然製品の開発への投資の増加により、大きな成長を遂げています。さらに、漁業、創薬、水産養殖の分野での進歩が増加しており、予測期間中の市場成長を後押しすると期待されています。

さらに、質の高い医療を提供するためのさまざまな効率的な治療薬に対する需要の高まりが、予測期間における海洋バイオテクノロジー市場のさらなる推進力となっています。海洋ベースの医薬品は、心血管疾患や神経障害などのさまざまな慢性疾患の治療用に開発されています。また、消費者の意識の高まりや環境に優しい製品を重視する傾向が強まっていることも、海洋バイオテクノロジーの需要をさらに高めています。

主要市場促進要因

持続可能なバイオベース製品に対する需要の高まり

主な市場課題

規制と法的枠組みの複雑さ

主要市場動向

海洋由来の医薬品と栄養補助食品の拡大

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の海洋バイオテクノロジー市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 種類別（生体活性物質と生体材料）
  • 技術別（微生物の分離・培養、培養非依存技術）
  • 用途別（水産養殖・食品、環境・健康、創薬、その他）
  • エンドユーザー業界別（バイオテクノロジー・医薬品、化学薬品、化粧品、その他）
  • 地域別
  • 企業別（2024）
• 市場マップ
  • 種類別
  • 技術別
  • 用途別
  • エンドユーザー業界別
  • 地域別

第6章 北米の海洋バイオテクノロジー市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の海洋バイオテクノロジー市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋地域の海洋バイオテクノロジー市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米の海洋バイオテクノロジー市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの海洋バイオテクノロジー市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 合併と買収
• 製品上市

第13章 海洋バイオテクノロジー市場：SWOT分析

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威/サービス

第15章 競合情勢

• Lonza Group
• Sea Run Holdings Inc
• PharmaMar S.A.
• Cyanotech Corporation
• New England Biolabs Inc.
• Qingdao Codo International Ltd
• Nutrex Hawai Inc.
• Royal DSM N.V.
• Prolume Ltd.
• CP Kelco US Inc.

第16章 戦略的提言

第17章 調査会社について・免責事項

Global Marine Biotechnology Market was valued at USD 6.35 billion in 2024 and is expected to reach USD 9.57 billion by 2030 with a CAGR of 7.08% during the forecast period. The global market for Marine Biotechnology is experiencing significant growth, driven by growing demand for natural products from marine derived like seaweed related products and increasing investments in the development of sustainable and natural products. Additionally, increasing advancement in the areas of fisheries, drug discovery and aquaculture are expected to boost market growth in the forecast period.

Additionally, increasing demand for different efficient therapeutics to deliver quality care is further propel the marine biotechnology market in the forecast period. Marine derived drugs are developed for the treatment of different chronic diseases such as cardiovascular disease, neurological disorder. Besides, growing consumer awareness and increasing emphasis on eco-friendly products is further enhancing the demand of marine biotechnology.

Key Market Drivers

Growing Demand for Sustainable Bio-based Products

The increasing global emphasis on sustainability and environmentally friendly alternatives is a significant driver for the marine biotechnology market. Marine organisms provide a vast and largely untapped source of bioactive compounds, enzymes, and polymers, which are being increasingly utilized in pharmaceuticals, nutraceuticals, cosmetics, and industrial applications. These natural, biodegradable materials offer a viable alternative to petroleum-based products, aligning with global sustainability goals.

Government support for bio-based economies further fuels this demand. For instance, the European Union's Bioeconomy Strategy, revised in 2018, places strong emphasis on utilizing renewable biological resources sustainably, including marine resources. The EU Blue Bioeconomy Report highlights how marine biotechnology supports sustainable growth and the circular economy, with funding initiatives such as the Horizon Europe program allocating billions of euros toward marine bioeconomy research and innovation.

Additionally, the U.S. Department of Energy (DOE) has supported research into marine algae for biofuel production under its Bioenergy Technologies Office (BETO). BETO-funded programs such as the Algae Technology Education Consortium (ATEC) aim to develop the U.S. algae workforce and support bio-product development. Marine biotechnology is thus seen as pivotal to national strategies for climate change mitigation, resource security, and economic development.

The rise in consumer awareness about the environmental impact of synthetic chemicals and plastics is also driving demand for marine-derived alternatives. As industries continue to seek sustainable raw materials, marine biotechnology stands to benefit, making it a key component of the global transition to a greener economy.

Key Market Challenges

Regulatory and Legal Framework Complexities

One of the most pressing challenges in the global marine biotechnology market is navigating the complex and fragmented regulatory landscape governing access to marine genetic resources. Marine bioprospecting often involves sampling from international waters or exclusive economic zones (EEZs), leading to jurisdictional ambiguities and compliance issues under international law. The Nagoya Protocol on Access and Benefit-sharing (ABS) under the Convention on Biological Diversity (CBD) aims to regulate the use of genetic resources and ensure fair benefit-sharing. However, its implementation varies significantly across countries, causing uncertainty for marine biotech companies. For instance, some countries enforce strict ABS laws that require long and bureaucratic approval processes, while others have more lenient or unclear regulations.

Moreover, marine biotechnology activities often intersect with maritime laws, environmental protection regulations, and ethical concerns over the exploitation of marine biodiversity. This complexity can delay research, restrict access to biological samples, and hinder international collaboration. In areas beyond national jurisdiction (ABNJ), legal frameworks for access and benefit-sharing remain under negotiation under the UN Convention on the Law of the Sea (UNCLOS). Governments are working to address these gaps. The 2023 UN High Seas Treaty, adopted to protect biodiversity in ABNJ, aims to establish clearer rules for marine genetic resource usage. However, practical implementation will take time, and industry stakeholders still face regulatory uncertainty in the interim.

Key Market Trends

Expansion of Marine-Derived Pharmaceuticals and Nutraceuticals

The growing recognition of marine organisms as sources of novel bioactive compounds is reshaping the pharmaceutical and nutraceutical industries. Marine-derived compounds have shown promising therapeutic potential, particularly in areas such as anti-inflammatory, anticancer, antimicrobial, and neuroprotective treatments. This is driving increased investment in marine-based drug discovery and nutraceutical development.

Marine-derived drugs such as Ziconotide, developed from cone snail venom for chronic pain, and Trabectedin, derived from sea squirts for cancer treatment, have demonstrated the clinical and commercial viability of marine bioproducts. According to the U.S. Food and Drug Administration (FDA), multiple marine-origin compounds are in various stages of clinical trials, indicating the growing interest in marine pharmaceuticals. Governments are also increasingly promoting the exploration of marine biodiversity for medical applications. The European Marine Biological Resource Centre (EMBRC-ERIC), supported by the European Commission, facilitates access to marine biodiversity and research infrastructure to accelerate drug discovery. Similarly, India's Department of Biotechnology has launched the Marine Bioresource and Biotechnology (MBB) program under its "Blue Economy" initiatives to support the development of marine-derived pharmaceuticals.

On the nutraceutical front, the demand for marine omega-3 fatty acids, astaxanthin, and marine collagen is rising due to their health benefits. Regulatory bodies such as the European Food Safety Authority (EFSA) and the U.S. FDA have established frameworks that support the marketing of these marine-based functional ingredients.

Key Market Players

• Lonza Group
• Sea Run Holdings Inc
• PharmaMar S.A.
• Cyanotech Corporation
• New England Biolabs Inc.
• Qingdao Codo International Ltd
• Nutrex Hawai Inc.
• Royal DSM N.V.
• Prolume Ltd.
• CP Kelco US Inc.

Report Scope:

In this report, the Global Marine Biotechnology Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Marine Biotechnology Market, By Type:

• Bioactive Substance
• Biomaterials

Marine Biotechnology Market, By Technology:

• Isolation and Cultivation of Microorganisms
• Culture-Independent Techniques

Marine Biotechnology Market, By Application:

• Aquaculture and Food Products
• Environment & Human Health
• Drug Discovery
• Others

Marine Biotechnology Market, By End User Industry:

• Biotechnology & Pharmaceuticals
• Chemicals
• Cosmetic
• Others

Marine Biotechnology Market, By Region:

• North America
  • United States
  • Mexico
  • Canada
• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
• Asia-Pacific
  • China
  • India
  • South Korea
  • Japan
  • Australia
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Marine Biotechnology Market.

Available Customizations:

Global Marine Biotechnology Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Marine Biotechnology Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Bioactive Substance v/s Biomaterials)
  • 5.2.2. By Technology (Isolation and Cultivation of Microorganisms v/s Culture-Independent Techniques)
  • 5.2.3. By Application (Aquaculture and Food Products, Environment & Human Health, Drug Discovery, Others)
  • 5.2.4. By End User Industry (Biotechnology & Pharmaceuticals, Chemicals, Cosmetic, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map
  • 5.3.1. By Type
  • 5.3.2. By Technology
  • 5.3.3. By Application
  • 5.3.4. By End User Industry
  • 5.3.5. By Region

6. North America Marine Biotechnology Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Technology
  • 6.2.3. By Application
  • 6.2.4. By End User Industry
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Marine Biotechnology Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Technology
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End User Industry
  • 6.3.2. Canada Marine Biotechnology Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Technology
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End User Industry
  • 6.3.3. Mexico Marine Biotechnology Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Technology
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End User Industry

7. Europe Marine Biotechnology Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Technology
  • 7.2.3. By Application
  • 7.2.4. By End User Industry
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Marine Biotechnology Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Technology
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End User Industry
  • 7.3.2. Germany Marine Biotechnology Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Technology
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End User Industry
  • 7.3.3. United Kingdom Marine Biotechnology Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Technology
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End User Industry
  • 7.3.4. Italy Marine Biotechnology Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Technology
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End User Industry
  • 7.3.5. Spain Marine Biotechnology Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Technology
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End User Industry

8. Asia-Pacific Marine Biotechnology Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Technology
  • 8.2.3. By Application
  • 8.2.4. By End User Industry
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Marine Biotechnology Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Technology
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End User Industry
  • 8.3.2. India Marine Biotechnology Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Technology
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End User Industry
  • 8.3.3. Japan Marine Biotechnology Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Technology
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End User Industry
  • 8.3.4. South Korea Marine Biotechnology Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Technology
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End User Industry
  • 8.3.5. Australia Marine Biotechnology Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Technology
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End User Industry

9. South America Marine Biotechnology Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Technology
  • 9.2.3. By Application
  • 9.2.4. By End User Industry
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Marine Biotechnology Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Technology
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End User Industry
  • 9.3.2. Argentina Marine Biotechnology Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Technology
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End User Industry
  • 9.3.3. Colombia Marine Biotechnology Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Technology
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End User Industry

10. Middle East and Africa Marine Biotechnology Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Technology
  • 10.2.3. By Application
  • 10.2.4. By End User Industry
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Marine Biotechnology Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Technology
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End User Industry
  • 10.3.2. Saudi Arabia Marine Biotechnology Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Technology
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End User Industry
  • 10.3.3. UAE Marine Biotechnology Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Technology
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End User Industry

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Marine Biotechnology Market: SWOT Analysis

14. Porters Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products/Services

15. Competitive Landscape

• 15.1. Lonza Group
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Sea Run Holdings Inc
• 15.3. PharmaMar S.A.
• 15.4. Cyanotech Corporation
• 15.5. New England Biolabs Inc.
• 15.6. Qingdao Codo International Ltd
• 15.7. Nutrex Hawai Inc.
• 15.8. Royal DSM N.V.
• 15.9. Prolume Ltd.
• 15.10. CP Kelco US Inc.

16. Strategic Recommendations

17. About Us & Disclaimer